A Phase 1 Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 (Part 1) and a Multiple Dose, Placebo-controlled Exploratory Safety, Pharmacokinetic and Pharmacodynamic Study in Type 2 Diabetes Mellitus Subjects with Chronic Kidney Disease (Part 2)
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in subjects with renal impairment and in Type 2 Diabetes Mellitus Subjects with Chronic Kidney Disease? Contact us by filling our your information to the right and we’ll respond to you.
Chisinau, Republic of Moldova
Sofia, Bulgaria, 1612
Bucharest, Romania, 10731